# Examining the role of perivascular fibroblasts in cerebral amyloid angiopathy during Alzheimers disease

> **NIH NIH R21** · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2020 · $196,875

## Abstract

ABSTRACT
Alzheimer's disease (AD) is a debilitating, chronic neurodegenerative disease that is the most common form of
dementia. The pathophysiology of AD includes the progressive loss of neurons and synapses throughout the
cerebral cortex as well as subcortical regions, and is characterized by the buildup of amyloid-beta (Aβ) plaques
and tau-containing neurofibrillary tangle pathologies throughout these regions. Aβ plaques have been reported
to be associated with neuronal and glial cells (parenchymal plaques), or associated with blood vessels
(vascular plaques termed cerebral amyloid angiopathy [CAA]). CAA is found in up to 90% of patients with AD,
and is thought to lead to impaired blood flow, altered vascular morphology, inflammation, microbleeds and
hemorrhage. Despite the importance of CAA, very little is known about how Aβ deposits around vessels.
There are two main hypotheses: First, vascular plaques are generated through the aberrant secretion of Aβ by
endothelial cells and/or mural cells. Second, vascular plaques are generated though dysfunction in clearance
of Aβ. Here we test a novel hypothesis: perivascular fibroblasts secrete Aβ in the generation of CAA. Work in
our lab has identified that perivascular fibroblasts are intimately associated with vascular Aβ plaques in AD
postmortem tissue. We have also identified that that perivascular fibroblasts robustly express amyloid
precursor protein (APP) and the enzymes that process amyloid (BACE1/2, PSEN1). Here, we will use a
conditional knockout approach to determine whether fibroblasts are the key cell type that secretes Aβ in the
generation of CAA in a well characterized mouse model of AD. We will also utilize single cell sequencing to
examine the cellular heterogeneity and gene expression of the perivascular fibroblasts as a function of time in
the mouse AD model. If we find that perivascular fibroblasts are key contributors to Aβ secretion in the buildup
of CAA, then this analysis will give insights into to the mechanism that leads to this vascular Aβ accumulation.
If we find that fibroblast secretion of Aβ is not necessary for the generation of CAA, this analysis will provide
vital information about how the fibroblasts change during the formation of vascular Aβ plaques, with which they
are intimately associated.

## Key facts

- **NIH application ID:** 9897476
- **Project number:** 5R21AG062918-02
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN DIEGO
- **Principal Investigator:** Richard Daneman
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $196,875
- **Award type:** 5
- **Project period:** 2019-04-01 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9897476

## Citation

> US National Institutes of Health, RePORTER application 9897476, Examining the role of perivascular fibroblasts in cerebral amyloid angiopathy during Alzheimers disease (5R21AG062918-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9897476. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*